ProQR Therapeutics - 48 Year Dividend History | PRQR

Historical dividend payout and yield for ProQR Therapeutics (PRQR) since 1971. The current TTM dividend payout for ProQR Therapeutics (PRQR) as of June 17, 2019 is $0.00. The current dividend yield for ProQR Therapeutics as of June 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.428B $0.000B
ProQR Therapeutics B.V. is a biotech company. It is engaged in the discovery and development of RNA-based therapeutics for the treatment of severe genetic disorders, with an initial focus on Cystic Fibrosis (CF). The Company's lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. ProQR Therapeutics B.V. is headquartered in Leiden, the Netherlands.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83